home | Hanmi Pharmaceutical co., ltd.

Products Search

Product Search

R&D No.1: R&D No.1
Contribute to human health: Dedication to promote human health | Hanmi Pharmaceutical devotes to promote human health and to serve corporate social responsibility.

News Centermore

Sanofi "Hanmi's efpeglenatide, to be added two new phase 3 clinical trials" Feb 08, 2018
Spectrum to file BLA for ROLONTIS(eflapegrastim) in 4Q Feb 08, 2018
Hanmi Annouces FDA Orphan Drug Designation for LAPSGlucagon Analog Feb 05, 2018
“Hanmi seeks global expansion with innovative drugs for NASH, rare diseases and targeted anti-cancer drugs” Jan 15, 2018
Hanmi’s Olita effective in treating lung cancer that has spread to brain Nov 21, 2017

Highlightsmore

Promotional videoHanmi Pharmaceuticals is a Korea-based global pharmaceutical company focused on the development and commercialization of new pharmaceutical products

R&D

LAPSCOVERY

Novel platform technology for biologics, Long Acting Protein / Peptide Discovery
BIO Discovery

Biomedicine for maximizing treatment interval and efficiency
NCE Discovery

Next generation targeted oncology, autoimmune & metabolic diseases

Global Products자세히

2017 Product Development Portfolio

Explore our clinical development programs

Hanmi at a glance

No 1. R&D Company for global new drug development

Compliance program

Compliance system and code of conduct